European Pharmaceutical Review

AUGUST 24, 2022

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. cancer agent or disease-relevant toxin. 2 The role of the antibody is to deliver the payload to a specific site such as a cancer cell.

Engineering 93

Engineering Side effects Marketing Patients 93

Pharmaceutical Technology

MAY 1, 2023

Under the deal terms, Shunxi will have licence to develop, manufacture, and commercialise CTH-004 to treat several solid tumours including ovarian cancer in Greater China, including Hong Kong, Taiwan, Mainland China, and Macao. In animal models of ovarian cancer, it demonstrated promising results.

Manufacturing 52

Manufacturing Patients Leads Pharmaceutical 52

World of DTC Marketing

DECEMBER 13, 2021

OPENING: American cancer patients spent more than $21 billion on their care in 2019. As cancer survival rates rise, so do the price tags of life-saving treatments. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug. What makes cancer such a financial killer? ScienceNews.com.

Food and Drug Administration 55

Food and Drug Administration Food Medical Insurance 55

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. With blood cancers, you inject the product, and the cells are there, and the target is there. The biology is different after these products are infused and demonstrating that in a product release is very complex.

Food and Drug Administration 59

Food and Drug Administration Engineering Patients Education 59

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

Evolve Your Success

JUNE 13, 2023

Kelly currently thrives in diagnostic testing sales, specifically in a department that deals with skin cancer prognosis. We’re looking at skin cancer like melanoma and squamous cell carcinoma. We take a look at the tumor biology of that. We provide a service for cancer patients. I work on the skin side.

Sales 52

Sales Medical sales Medical Doctors 52

European Pharmaceutical Review

NOVEMBER 10, 2022

BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). During her PhD at EMBL-CRG and Post-Doc at the Cancer Research Cambridge Institute, she developed different microscopy methods to understand cell division. Physical characterisation.

Medicine 103

Medicine Distribution Engineering Electronics 103